Challenges, Opportunities and Facilitators in Implementing Personalised Medicine

In 2019, the International Consortium for Personalised Medicine (ICPerMed) has developed a vision of how the use of personalised medicine (PM) approaches will promote “next-generation” medicine in 2030, more firmly centred on the individual’s personal characteristics, leading to improved health outcomes within sustainable healthcare systems through research, development, innovation and implementation for the benefit of patients, citizens, and society. However, there are significant hurdles that healthcare professionals, healthcare systems managers, decision-makers, patient organisations etc. must overcome to implement PM. With this document, ICPerMed aims to provide recommendations to increase preparedness of stakeholders by identifying actionable measures to be implemented for the realisation of PM.